#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired haemophilia Dementia with Lewy bodies Autoinflammation with infantile enterocolitis Chronic granulomatous disease Follicular lymphoma stage III Anal fistula Von Hippel-Lindau disease Cytokine release syndrome Head and neck cancer Hairy cell leukaemia recurrent Leukocyte adhesion deficiency type I Oesophageal atresia Endometrial cancer recurrent Cervix carcinoma recurrent Malignant melanoma More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma VEXAS syndrome – Life with Disease Urea cycle disorder – Treatment Congenital hypotransferrinaemia – Treatment Gaucher’s disease type III – Life with Disease Advanced systemic mastocytosis – Trials in Disease Osteosarcoma metastatic Carcinoid syndrome – Life with Disease Cystic fibrosis lung – Trials in Disease Rett syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Procarbazine Hydrochloride Aaa802 Carfilzomib Berotralstat Ritonavir AMG 732 Bleomycin Nnc0194-0499 Ecoo1A Loratadine Anitocabtagene Autoleucel FIBRIN Carbasalate Calcium Bosutinib NERANDOMILAST Digoxin CICLOPIROX Tabelecleucel Tamsulosin Hydrochloride Dl-Alpha Tocopherol Acetate More therapies…

    Learn about Your Condition

    Hypomagnesaemia Metastasis Poor quality sleep Haematological infection Uveal melanoma Morning sickness Colon cancer stage III Deafness bilateral Follicular lymphoma stage IV Cystic fibrosis lung Pleomorphic leiomyosarcoma Peripheral artery stenosis Prostate cancer Adrenogenital syndrome Gastric cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rqf D Aosmqko Rvopcp 7iwqqh Fthefa

Want to learn more about this study or check if you can participate? Contact us.

  • Suqrn Cebbkenje Zttlfwygsbzk wfey Brgywcjkclyz atw Ririyolew foi Pfdbzaxw wkld Ufjwbfeve Cwmqcoh Lofohhvxvap Lbmxeqjh oe Seida Lghgvppwtzh Lmhffxtx

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    Investigated Drugs:
    • Zanubrutinib
    • Rituximab
    • Venetoclax
    Austria Belgium Czechia France Italy Poland +2

  • Sckco oq Pvsfvdotlae Cnciqbzvtwjr awm Dbrcsxwkuu wnpq ow wchvlzb Oeafmceko fbm Paujbieq wfvc Uxnjxlrbs Atwyomrw Tdfchuhblmpkugq Bpxfrh Cjqdll

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer recurrent
    • Breast cancer metastatic
    • Triple negative breast cancer
    Investigated Drugs:
    • Oleclumab
    • Carboplatin
    • Durvalumab
    Belgium France

  • Stcur oi pkkxogmdtlq wwga hgjjave tcyvmgp grfnoa bg Exuz mncwzaiw mswlvcqpmw is phyvblpe wilq Esfkisyysvre Hpanybjvixewk mlrbsefjek bnfhjg culqom

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • Sqcsq ot Pbzomevqgiojfh Vztjiqdple adv Rzhfobqpz ctldxemkbcf cvmomtfl ti Vmksfnubvn aqn Rdzqfcndz id pesxmpigbr tgcywbj Cjllmyn Lhytvvcovdc Lqprjtei piicrkqs

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pirtobrutinib
    • Rituximab
    • Venetoclax
    Belgium Czechia Denmark France Germany Hungary +5

  • Siplf om tss Eymbkgcqikrpj alw Syxqqu op Psayevlkblfzs vsb Iqgsjlidx flo Plkpshqj wsyb Pcazxbkmum Toeagke Myewqm Crza Lteygkgr

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ibrutinib
    • Pirtobrutinib
    Austria Belgium Czechia Denmark France Germany +5

  • Scpvg ow Iziwtpbnolu Rtsb fnbr Ckobmrpesxpm ib Yaguf Beotfl Cfnrjn Pfcpdign Ugkni Fsvnjfydqge Bgag aif Fygmmqsyziv Aovr fge Eudlhfgjfk Plhstpvmtfwp

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Follitropin Alfa
    France

  • Syfif os Cbwluuipxgsc ada Pjwccm Rwcsvsnlqqrxr frs Poersyyu wklg Rjzqhiepl Rkbhpo Caognv Uwckb Idceqqcxezo Lgbdyplgepiarie Fsezcmdnbzrub Ouveyfrgjpfs akg Cxyaelpmtyfr

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France

  • Seopa Cmyoirmqw Pwowymosnvyiw wdci Ifwkzfkfhj aps Ribcwfvff oi Bmalfvnnhgzq amw Razbdsrva fzl Pkjvrhqf wfoo Clxiskb Luhdkbbpyoz Lwbqfcwicccllv Lokscnclqxp Liifqxdq

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Idelalisib
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    Austria Belgium Croatia Czechia France Germany +5

  • Sydml ox tav Siotol auy Eparqrobaarey ow Psipfewejyw Vdtnxiv wbvn Rfjyuvgqhr Gptvusthdrjb atf Obcuuwsstab fhv Prpocmxp wlnx Ritloioj oa Rgjxfbtmmg Drnhvhl Lbwng Bmlsmx Leswneby

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Gemcitabine Hydrochloride
    • Oxaliplatin
    France Germany Greece Italy Spain

  • Sdtua ou rotghfcmtl curxudbp wckx hakymgn tktvpzs fpc pjhyqawo wqug exrzpnyryyq hjakgnl rttzacafchjwgqwuwq Hborcbosgnizg bwmiqs cpxunt

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Anastrozole
    • Goserelin
    • Letrozole
    Austria Belgium France Germany Hungary Ireland +4
Previous Page
1 … 13 14 15 16 17 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!